Journal of Personalized Medicine (Apr 2023)

Cardiac Rehabilitation in Severe Heart Failure Patients with Impella 5.0 Support via the Subclavian Artery Approach Prior to Left Ventricular Assist Device Implantation

  • Miho Shimizu,
  • Hiroaki Hiraiwa,
  • Shinya Tanaka,
  • Yohei Tsuchikawa,
  • Ryota Ito,
  • Shingo Kazama,
  • Yuki Kimura,
  • Takashi Araki,
  • Takashi Mizutani,
  • Hideo Oishi,
  • Tasuku Kuwayama,
  • Toru Kondo,
  • Ryota Morimoto,
  • Takahiro Okumura,
  • Hideki Ito,
  • Tomo Yoshizumi,
  • Masato Mutsuga,
  • Akihiko Usui,
  • Toyoaki Murohara

DOI
https://doi.org/10.3390/jpm13040630
Journal volume & issue
Vol. 13, no. 4
p. 630

Abstract

Read online

Impella 5.0 circulatory support via subclavian artery (SA) access may be a safe approach for patients undergoing cardiac rehabilitation (CR). In this case series, we retrospectively analyzed the demographic characteristics, physical function, and CR data of six patients who underwent Impella 5.0 implantation via the SA prior to left ventricular assist device (LVAD) implantation between October 2013 and June 2021. The median age was 48 years, and one patient was female. Grip strength was maintained or increased in all patients before LVAD implantation (pre-LVAD) compared to after Impella 5.0 implantation. The pre-LVAD knee extension isometric strength (KEIS) was less than 0.46 kgf/kg in two patients and more than 0.46 kgf/kg in three patients (unavailable KEIS data, n = 1). With Impella 5.0 implantation, two patients could ambulate, one could stand, two could sit on the edge of the bed, and one remained in bed. One patient lost consciousness during CR due to decreased Impella flow. There were no other serious adverse events. Impella 5.0 implantation via the SA allows mobilization, including ambulation, prior to LVAD implantation, and CR can be performed relatively safely.

Keywords